Form 4: STERIS plc Executive Reports Routine Stock Vesting and Tax Withholding
Insider Transaction Report
Mary Clare Fraser, SVP & Chief HRO of STERIS plc, reported the vesting of restricted shares and the subsequent withholding of shares for tax obligations, a standard insider transaction.
Summary
- Mary Clare Fraser, SVP & Chief HRO of STERIS plc (STE), reported a transaction on June 2, 2025, involving the disposition of ordinary shares.
- A total of 548 ordinary shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of restricted stock.
- These 548 shares were part of 1,836 restricted shares that vested on June 2, 2025, which were originally awarded to Ms. Fraser on June 2, 2021.
- The shares withheld for tax purposes were valued at the NYSE closing market price of $242.08 per share on June 2, 2025.
- Following this transaction, Ms. Fraser beneficially owns 10,584 ordinary shares directly.
- As of June 3, 2025, 7,073 of these ordinary shares remain restricted, with vesting schedules as follows: 692 shares on October 1, 2025; 2,313 shares on June 1, 2026; 2,028 shares on June 2, 2026; and 2,040 shares on June 4, 2027.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax purposes related to executive compensation, with no direct positive or negative implications for company performance or outlook.
Positives
- The vesting of restricted shares indicates the fulfillment of long-term incentive compensation for a key executive.
- The transaction reflects a routine and expected process for executive compensation and tax compliance.
Negatives
- The disposition of shares was solely for tax withholding purposes, not a voluntary sale by the executive.
Future Outlook
The document outlines future vesting dates for Ms. Fraser's remaining restricted shares, indicating continued long-term incentive alignment.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies, reflecting standard executive compensation practices involving restricted stock units and tax withholdings upon vesting.
Stakeholder Impact
- Shareholders: This is a routine insider transaction that provides transparency into executive stock ownership and compensation, generally not impacting share price significantly.
Next Steps
- Future vesting of 692 restricted shares on October 1, 2025.
- Future vesting of 2,313 restricted shares on June 1, 2026.
- Future vesting of 2,028 restricted shares on June 2, 2026.
- Future vesting of 2,040 restricted shares on June 4, 2027.
Key Dates
| Date | Description |
|---|---|
| 2021-06-02 | Date when 1,836 ordinary shares were awarded to Ms. Fraser. |
| 2025-06-02 | Date of transaction; 1,836 restricted shares vested, and 548 shares were withheld for taxes. |
| 2025-06-03 | Date as of which 7,073 ordinary shares remain restricted. |
| 2025-10-01 | Date when restrictions lapse on 692 ordinary shares. |
| 2026-06-01 | Date when restrictions lapse on 2,313 ordinary shares. |
| 2026-06-02 | Date when restrictions lapse on 2,028 ordinary shares. |
| 2027-06-04 | Date when restrictions lapse on 2,040 ordinary shares. |
Keywords
STERIS plc, STE, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Stock Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.